116 related articles for article (PubMed ID: 1833867)
1. Suppression of mixed lymphocyte reactivity by murine bone-marrow-derived suppressor factor--inhibition of proliferation due to a deficit in IL-2 production.
Saffran DC; Singhal SK
Transplantation; 1991 Oct; 52(4):685-90. PubMed ID: 1833867
[TBL] [Abstract][Full Text] [Related]
2. Cell lines derived from human autorosette-forming cells with suppressive activity.
Michlin H; Schlesinger M; Kalechman Y; Sredni B
Nat Immun Cell Growth Regul; 1990; 9(1):49-59. PubMed ID: 2139496
[TBL] [Abstract][Full Text] [Related]
3. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
4. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction.
Weigensberg M; Morecki S; Weiss L; Fuks Z; Slavin S
J Immunol; 1984 Feb; 132(2):971-8. PubMed ID: 6140288
[TBL] [Abstract][Full Text] [Related]
7. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
Jadus MR; Parkman R
J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
[TBL] [Abstract][Full Text] [Related]
8. Production of human bone marrow-derived suppressor factor. Effect on antibody synthesis and lectin-activated cell proliferation.
Mortari F; Singhal SK
J Immunol; 1988 Nov; 141(9):3037-42. PubMed ID: 2971736
[TBL] [Abstract][Full Text] [Related]
9. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
Serreze DV; Leiter EH
J Immunol; 1988 Jun; 140(11):3801-7. PubMed ID: 2897395
[TBL] [Abstract][Full Text] [Related]
10. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
Yoshida M; Takeuchi M; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
[TBL] [Abstract][Full Text] [Related]
13. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
15. Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation.
Chaudhri G; Clark IA; Hunt NH; Cowden WB; Ceredig R
J Immunol; 1986 Oct; 137(8):2646-52. PubMed ID: 2944959
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
17. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
Isakov N; Altman A
J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes.
Yamamoto H; Hirayama M; Genyea C; Kaplan J
J Immunol; 1994 Apr; 152(8):3842-7. PubMed ID: 8144953
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
Suzuki R; Suzuki S; Igarashi M; Kumagai K
J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
[TBL] [Abstract][Full Text] [Related]
20. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
Mellow L; Sabbadini E
Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
